Professional Documents
Culture Documents
U COLLEGE OF
PHARMACY
RAMANAGARAM-571511
SEMINAR ON
DRUG DISTRIBUTION & FACTORS
AFFECTING
PRESENTED BY SUBMIT TO
AZIM ARSHI VASEEHA BANU.T.S
1ST M.PHARMA ASSISTANT PROFESSOR
DEPARTMENT OF PHARMACEUTICS
1
DRUG DISTRIBUTION
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
BODY WATER
IN VARIOUS
ORGEN
2
SPECIFIC
BLOOD 1 4 3 ORGEN
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
TISSUE E.g.
DEPARTMENT OF PHARMACEUTICS
Fat
sulphonamides become
uniformly Distributed
through the body water.
4
Distribution Patterns
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
3)
3) AA few
few drug
drug are
are concentrated
concentrated
specifically
specifically inin 11 or
or more
more tissue
tissue
that
that may
may or or may
may not
not bebe site
site of
of
action.
action.
4)
4) Most
Most drug
drug exhibit
exhibit aa non-uniform
non-uniform
distribution
distribution in in the
the body
body with
with the
the
variations
variations that
that is
is largely
largely
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
determination
determination by by their
their ability
ability to
to
pass
pass through
through the the membrane
membrane
DEPARTMENT OF PHARMACEUTICS
&their
&their lipid/water
lipid/water solubility.
solubility. The
The
highest
highest concentration
concentration are are often
often
present
present inin Kidney,
Kidney, Liver,
Liver,
5
FACTORS AFFECTING DRUG DISTRIBUTION
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
Rate of distribution
Rate of distribution
Extent of distribution
Membrane permeability (Capillaries Membrane
permeability)
Blood perfusion rate
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
DEPARTMENT OF PHARMACEUTICS
6
Membrane permeability
(Capillary Membrane
permeability)
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
very rapidly.
Water soluble compounds
penetrate more slowly at a rate more
dependent on their size.
7
Membrane permeability
(Capillary Membrane
permeability)
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
8
There are two
There are two deviations
deviations to
to the
the typical
typical capillary
capillary structure
structure
which
which result
result in
in variation
variation from
from normal
normal drug
drug tissue
tissue permeability
permeability
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
Permeability is
greatly increased in
the renal capillaries
by pores in the
membrane of the
endothelial cells,
and in specialized
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
hepatic capillaries,
DEPARTMENT OF PHARMACEUTICS
On
On the
the other
other hand
hand brain
brain
capillaries
capillaries seem
seem to to have
have
impermeable
impermeable walls
walls
restricting
restricting the
the transfer
transfer of
of
molecules
molecules from
from blood
blood toto
brain
brain tissue.
tissue. Lipid
Lipid soluble
soluble
compounds
compounds can can bebe readily
readily
transferred
transferred But
But the
the
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
transfer
transfer of
of polar
polar
DEPARTMENT OF PHARMACEUTICS
substances
substances is is severely
severely
restricted.
restricted. This
This is is the
the
basis
basis of
of the
the "blood-brain"
"blood-brain"
barrier
barrier
10
That
That means
means Membrane
Membrane Permeability
Permeability depend upon Physico-
depend upon Physico-
Chemical
Chemical Properties
Properties such
such as
as molecular
molecular size,
size, lipid
lipid solubility,
solubility,
And
And Physiologic
Physiologic Barriers
Barriers such
such as.
as.
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
Simple
Simple capillary
capillary Simple
Simple cell
cell membrane
membrane
endothelial
endothelial barrier
barrier barrier
barrier
Blood
Blood Brain
Brain barrier
barrier Cerebrospinal
Cerebrospinal barrier
barrier
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
DEPARTMENT OF PHARMACEUTICS
Placenta
Placenta barrier
barrier Blood-Testis
Blood-Testis barrier
barrier
11
Simple
Simple capillary
capillary
endothelial
endothelial barrier
barrier
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
All
All the
the Drug,
Drug, ionized
ionized or
or
unionized
unionized with
with a
a
molecular
molecular size size 600
600
Dalton,
Dalton, diffuse
diffuse through
through
the
the endothelium
endothelium and and
into
into the the interstitial
interstitial
fluid.
fluid. Only
Only drugs
drugs bound
bound
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
the
the blood
blood component
component
are
are restricted
restricted because
because
DEPARTMENT OF PHARMACEUTICS
of
of the
the large
large molecular
molecular
size
size of
of complex
complex
12
Blood
Blood Brain
Brain barrier
barrier
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
DEPARTMENT OF PHARMACEUTICS
The
The brain
brain capillaries
capillaries consist
consist of
of endothelial
endothelial cell
cell which
which
are
are joined
joined to to one
one another
another byby continuous
continuous tight
tight
intracellular
intracellular junction
junction comprising
comprising what
what is
is called
called as
as blood
blood
brain
brain barrier.
barrier.
13
Cerebrospinal
Cerebrospinal barrier
barrier
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
DEPARTMENT OF PHARMACEUTICS
CSF
CSF is
is formed
formed mainly
mainly by
by choroid
choroid plexus
plexus of
of the
the lateral,
lateral, 3
rd
3rd
&
& 4
4th ventricles
th
ventricles &
& similar
similar in
in composition
composition to
to the
the EHF
EHF of of
brain.
brain.
14
Placenta
Placenta barrier
barrier
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
DEPARTMENT OF PHARMACEUTICS
The
The maternal
maternal & & the
the fetal
fetal blood
blood vessels
vessels are
are separated
separated by
by
number
number of
of tissue
tissue layer
layer made
made of
of fetal
fetal trophoblast
trophoblast basement
basement
membrane
membrane & & endothelium
endothelium which
which together
together constitute
constitute the
the
placental
placental barrier.
barrier.
15
Blood perfusion rate
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
Perfusion
Perfusion rate is define as
volume of blood that
flows/minute/tissue volume.
Perfusion rate of tissue varies
from approximately
10ml/min/ml for lungs to 0.025
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
16
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
DEPARTMENT OF PHARMACEUTICS
Poor Moderator
Moderator perfusion
Poor perfusion
perfusion perfusion
High
High perfusion
perfusion
Organ
FAT
LUNGS
SKIN
BONE
LIVER
BRAIN
HEART
KIDNEY
MUSCLES
5000
250
200
700
200
350
1350
1250
1000
organs
(ml/min)
Blood flow
10.2
rate
0.5
0.6
0.8
4.5
0.02
0.03
0.033
0.025
Perfusion
(ml/min/ml)
Blood perfusion rate in various
17
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
Penicillin
Penicillin is
is quite
quite polar
polar thus
thus slowly
slowly permeable.
permeable.
Permeability
Permeability limited
limited transfer
transfer is
is faster
faster in
in muscle
muscle as
as
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
muscle
muscle capillaries
capillaries are
are less
less restrictive.
restrictive. Thus
Thus
DEPARTMENT OF PHARMACEUTICS
transfer
transfer of
of penicillin
penicillin is
is faster
faster in
in muscle
muscle than
than brain
brain
19
Extent of distribution
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
PLASMA PROTEIN
BINDING TISSUE BINDING
APPARENT
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
VOLUME OF
DEPARTMENT OF PHARMACEUTICS
DISTRIBUTION
DRUG BINDING TO
ERYTHROCYTES
20
PLASMA PROTEIN BINDING
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
Acidic Basic
Drug drug
Binding site Albumins Globulins, 1,
2, 1, 2,
Example Bilirubin, Bile Adenisine,
Drug
acids, Fatty Quinacrine,
Acids, Vitamin Quinine,
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
C, Salicylates, Streptomycin,
DEPARTMENT OF PHARMACEUTICS
Sulfonamides, Chloramphenic
Barbiturates, ol, Digitoxin,
Phenylbutazone Ouabain,
22
, Penicillins, Coumarin
FACTOR INVOLVED
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
23
FACTOR INVOLVED
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
Example
Phenyllbutazone and Salicylates displace
tolbutamide to give an increased effect,
hypoglycemia
The displacement of warfarine by phenyl
butazone leads to nearly 100 folds increase in
free drug con. Which can result in clinical
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
significant reaction.
DEPARTMENT OF PHARMACEUTICS
given by
u
uf = C /C
u
u
24
PERCENT UNBOUND FOR SELECTED DRUGS
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
Diazepam 3-4
DEPARTMENT OF PHARMACEUTICS
Warfarin 0.5
Phenylbutazone 1-5
Dicumarol 1-3 25
TISSUE BINDING
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
a) Specific protein in
tissues
Example
b) Accumulation in
The con. Of chloroquine
endocytotic vesicles
in the liver is due to
(E.g. Gentamycin in
the binding of drug to
renal proximal tube)
DNA. Paracetamol
c) Binding to nucleic
bind irreversibly to
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
acid
liver tissue resulting
DEPARTMENT OF PHARMACEUTICS
d) Binding to Calcium
hepatotoxicity
e) Accumulation in lipid
depots
30
APPARENT VOLUM OF DISTRIBUTION
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
31
APPARENT VOLUM OF DISTRIBUTION
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
32
DRUG BINDING TO ERYTHOCYTES
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
Drug
Drug like
like phenytoine
phenytoine ..etc
..etc bind
bind to
to
Hemoglobin hemoglobin
hemoglobin
Drug
Drug like
like Acetazolamide,
Acetazolamide,
Carbonic anhydrase Chlorthalidone
Chlorthalidone
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
DEPARTMENT OF PHARMACEUTICS
Imipramine &
RBC membrane Chlorpromazine
33
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
DEPARTMENT OF PHARMACEUTICS
factor
Age
Miscellaneous
Obesity
Pregnancy
Diet
Drug
interaction
34
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
REFERENCES
D.M.BRAHMANKAR, SUNIL B.JAISWAL P 76-90
Dr.SHOBHA RANI , P 138-150
Rowland, M. and Tozer, T.N, 1995 Clinical
Pharmacokinetics Concepts and Applications, 3rd
ed., Williams & Williams. Media, PA
Shargel, L., Wu-Pong, S. and Yu, A.B.C. 2005
Applied Biopharmaceutics and Pharmacokinetics,
5th ed., McGraw-Hill, New York, NY
Niazi, S. 1979 Textbook of Biopharmaceutics and
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA
35
Ritschel, W.A. and Kearns, G.L. 2004 Handbook of
Basic Pharmacokinetics ... including Clinical
SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
p49, 53
Abernethy, D.R., Greenblatt, D.J, Divoll, M. et al.
260-270
DEPARTMENT OF PHARMACEUTICS
http://www.boomer.org/c/p4/c18/c1802.html
http://www.boomer.org/c/p1/Ch18/Ch1802.html
36
PRESENTED BY AZIM ARSHI, 1ST M.PHARMA SUBMIT TO VASEEHA BANU.T.S ASSISTANT PROFESSOR
DEPARTMENT OF PHARMACEUTICS
THANKYOU
37